| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 232.13B | 226.38B | 188.57B | 185.29B | 160.62B | 145.14B |
| Gross Profit | 66.03B | 62.76B | 52.73B | 52.48B | 48.05B | 46.09B |
| EBITDA | 24.99B | 22.74B | 20.47B | 21.64B | 19.23B | 17.30B |
| Net Income | 13.30B | 11.96B | 16.49B | 13.19B | 10.98B | 9.41B |
Balance Sheet | ||||||
| Total Assets | 288.90B | 290.23B | 277.20B | 212.69B | 194.80B | 175.13B |
| Cash, Cash Equivalents and Short-Term Investments | 28.90B | 30.35B | 23.33B | 15.27B | 24.82B | 19.26B |
| Total Debt | 72.30B | 68.94B | 66.45B | 33.21B | 27.60B | 29.68B |
| Total Liabilities | 134.33B | 136.94B | 128.60B | 92.78B | 89.16B | 78.21B |
| Stockholders Equity | 139.09B | 138.37B | 134.14B | 113.80B | 99.69B | 91.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 16.06B | -15.90B | -11.70B | 9.52B | 10.68B |
| Operating Cash Flow | 0.00 | 24.01B | -8.99B | -7.23B | 12.95B | 13.94B |
| Investing Cash Flow | 0.00 | -9.60B | -10.56B | -4.72B | -3.30B | -3.90B |
| Financing Cash Flow | 0.00 | -5.98B | 25.95B | 1.90B | -5.31B | -5.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥70.33B | 9.50 | ― | 2.63% | -6.00% | -13.74% | |
75 Outperform | ¥277.44B | 14.76 | ― | 2.50% | 6.16% | 17.11% | |
73 Outperform | ¥261.07B | 14.24 | ― | 1.65% | 14.49% | -21.17% | |
71 Outperform | ¥475.50B | 26.32 | 5.25% | 2.13% | -2.23% | 130.96% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥368.21B | 197.68 | 5.94% | 0.56% | 6.22% | ― | |
55 Neutral | ¥514.96B | -6.48 | 1.88% | 6.16% | 1.98% | -48.28% |